Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set the stage for the two-day interactive science conference. CannX was created as a interactive forum for top global leaders in all areas of medical cannabis to explore the latest scientific and clinical research, agricultural practices and innovation, and business opportunities in medical cannabis.
Joining Dr. Mechoulam in delivering keynote speeches will be Donald Abrams, Professor of Clinical Medicine at the University of California, Dr Kirsten R. Müller-Vahl Director of Tourette Syndrome Clinic at the Medical School of Hannover, Germany, and Prof. Michael Dixon Expert for the effects of Environmental on cannabis grow at School of Environmental Sciences, The University of Guelph, Canada.
CannX will feature research on:
- Dementia and Cannabis TreatmentUtilizing the “Entourage Effect” for the Alleviation of Sleep Disorder Symptoms
- What Is Known about Marijuana’s Potential Utility in Treating Tourette Syndrome?
- The Health Effects of Cannabis and Cannabinoids: Will Cannabis Cure Cancer?
- The Latest Space Exploration Life Support Technology Finds Applications in Medical Cannabis Production
Follow this track and explore the latest scientific and clinical research.
Benefit from it if you are:
✓ Scientific Researcher
✓ Medical Practitioner
✓ Medical Cannabis Organization
New Technologies, New Opportunities
Follow this track and get insight to the latest technologies and business opportunities in medical cannabis.
Benefit from it if you are:
✓ Consultant
✓ Lawyer & Accountant
✓ “Start-up” (& those looking to be)
✓ Journalist
AGR: Advanced Agriculture and Production
Follow this track and be up-to-date with the new agricultural practices and innovation.
Benefit from it if you are:
✓ Medical Cannabis Producers
✓ Plant breeders
✓ Agronomists
✓ Transport & Logistics
✓ Equipment, Seed, Lighting, Soil Nutrient, Security Suppliers
CannX registration deadline is October 4, register before October 3rd and save.